"Infertility treatment heads first drugs on FDA’s new priority review scheme" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

The upheaval at the Food and Drug Administration appears to be taking a toll on the pharmaceutical industry, according to a ...

The company will begin its domestic investment by starting construction on a $3 billion pharmaceutical manufacturing site in ...

Merck began construction on a previously announced $3 billion manufacturing facility in Elkton, Va., as the pharmaceutical industry, under pressure from the Trump administration, invests in U.S.

The U.S. FDA approved 17 drugs in September 2025, following 18 approvals in August and 17 in July. That brings the ...

Oct. 19, GNA-The Food and Drugs Authority (FDA) has suspended the operations of nine sachet water producers in the Western North ...

The FDA named the first nine products to undergo a new expedited review process that takes 1 to 2 months, the agency announced on Thursday.

The Trump administration struck a deal with EMD Serono, the health care business of Merck KGaA in the United States and ...

The FDA has named the first nine medications selected for its national priority review voucher program, which aims to shorten drug review timelines to ...

A gene therapy from Regeneron, a pancreatic cancer medicine from Revolution Medicines and a porphyria drug from Disc Medicine ...

The Commissioner’s National Priority Voucher awards companies that align with specific national priorities—such as boosting ...

The FDA in June launched the new Commissioner's National Priority Voucher pilot program under which it could issue vouchers ...